Michael A. London is one of the founding partners in the law firm of Douglas & London. Mr. London was born in New York, New York. He obtained a Bachelor of Arts Degree from the University of Miami, in Coral Gables, Florida, and a Juris Doctorate Degree from Brooklyn Law School in New York. Mr. London is admitted and licensed to practice law in the State of New York and the State of New Jersey, as well as in the United States District Courts for the Eastern District, Southern District, and Western District of New York, as well as the District of New Jersey. He is also admitted to practice in the Court of Federal Claims in Washington, D.C.
Since obtaining his law degree, he has devoted his entire career to always representing injury victims and consumers, primarily in mass tort settings. Formerly a partner at another national plaintiffs’ law firm, his practice area in the law has always focused on, and continues to focus on, products liability and complex litigation with an emphasis in pharmaceutical litigation.
Mr. London is well known in the products liability and pharmaceutical and medical device areas of the law as one of the nations most skilled attorneys. The firm’s verdicts and settlements are just one measure of the success. Another measure is that he has been appointed by numerous judges across the country to serve on various steering committees in some of the country’s largest civil cases over the past 15 years.
Mr. London has also represented hundreds of women exposed, in utero, to the drug Diethylstilbestrol (“DES”) in litigation pending before the Honorable Jack B. Weinstein. He has represented and continues to represent children and families who were victims of the medical device/procedure Chorionic Villi Sampling, as well as many other toxic and mass torts for which formal plaintiff steering committees were not established. He has used this knowledge and vast experience in representing young children today who are still being exposed to dangerous medications while in utero, due to drug companies’ failure to test for or warn of these dangerous side effects. Examples of these dangerous medications are:
- Antidepressants such as Paxil, Zoloft, Prozac, Lexapro, Celexa, Wellbutrin and Effexor (SSRIs and SNRIs);
- Depakote (anti-seizure medication);
- Topamax (anti-seizure medication);
- Proton pump inhibitors such as Nexium, Prilosec, Zegerid, Prevacid, Protonix, or AcipHex (digestive track medication)
In addition to the above, Mr. London has extensive experience with heart device litigation where he haw represented hundreds of injured clients across the country in the recent implantable defibrillator litigations (e.g. Guidant implantable defibrillators, Medtronic implantable defibrillators, and Medtronic Sprint Fidelis Leads, MDL-1708, MDL-1726, and MDL-1905, respectively). He and his firm also represented over 500 people who were injured by the Cox-2 inhibitor medications Vioxx, Bextra, and Celebrex.
Mr. London has served as trial counsel in multiple tobacco trials, including the first successful verdict against the tobacco industry in the state of New York, when he and Firm partner Gary Douglas secured a $20 million plus verdict for the widow of a former smoker. Mr. London previously served as co-trial counsel in the first two tobacco cases to be tried in the State of New York – both in the year 2000. Mr. London has also been actively involved in prosecution and appellate issues in personal injury tobacco litigation across the country, including in San Francisco, Missouri, and Florida. Mr. London was co-trial counsel in the very first Norplant products liability trial in the State of New York – and shortly after the verdict in his trial, a national settlement of over $40 million was reached.